Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer

被引：0
|
作者：
Xiaohe Su
Kaifeng Jin
Qiji Guo
Ziyue Xu
Zhaopei Liu
Han Zeng
Yiwei Wang
Yu Zhu
Le Xu
Zewei Wang
Yuan Chang
Jiejie Xu
机构：
[1] Fudan University,NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences
[2] Fudan University,Department of Urology, Zhongshan Hospital
[3] Fudan University Shanghai Cancer Center,Department of Urology
[4] Shanghai Jiao Tong University School of Medicine,Department of Urology, Shanghai Ninth People’s Hospital
[5] Shanghai Jiao Tong University School of Medicine,Department of Urology, Ruijin Hospital
来源：
British Journal of Cancer | 2024年 / 130卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：852 / 860
页数：8
相关论文
共 50 条
  • [41] Platinum-Based Chemotherapy is Associated with Altered PD-L1 Expression in Lung Cancer
    Moldyay, J.
    Rojko, L.
    Teglasi, V.
    Fabian, K.
    Pipek, O.
    Vagyolgyi, A.
    Agocs, L.
    Fillinger, J.
    Kajdacsi, Z.
    Timar, J.
    Dome, B.
    Szallasi, Z.
    Reiniger, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S733 - S733
  • [42] Biomarkers of response to PD-1/PD-L1 inhibition
    Vareki, Saman Maleki
    Garrigos, Carmen
    Duran, Ignacio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 116 : 116 - 124
  • [43] Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
    Mengling Wu
    Qianrui Huang
    Yao Xie
    Xuyi Wu
    Hongbo Ma
    Yiwen Zhang
    Yong Xia
    Journal of Hematology & Oncology, 15
  • [44] Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
    Wu, Mengling
    Huang, Qianrui
    Xie, Yao
    Wu, Xuyi
    Ma, Hongbo
    Zhang, Yiwen
    Xia, Yong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [45] PD-1/PD-L1 Axis in Lung Cancer
    Santini, Fernando C.
    Hellmann, Matthew D.
    CANCER JOURNAL, 2018, 24 (01): : 15 - 19
  • [46] PD-1/PD-L1 Inhibitors in Cervical Cancer
    Liu, Yuncong
    Wu, Li
    Tong, Ruizhan
    Yang, Feiyue
    Yin, Limei
    Li, Mengqian
    You, Liting
    Xue, Jianxin
    Lu, You
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [47] PD-1 AND PD-L1 EXPRESSION IN OVARIAN CANCER
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Fiegl, H.
    Marth, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 64 - 64
  • [48] Antagonists of PD-1 and PD-L1 in Cancer Treatment
    Lipson, Evan J.
    Forde, Patrick M.
    Hammers, Hans-Berg
    Emens, Leisha A.
    Taube, Janis M.
    Topalian, Suzanne L.
    SEMINARS IN ONCOLOGY, 2015, 42 (04) : 587 - 600
  • [49] PD-1 and PD-L1 expression in ovarian cancer
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Reimer, D.
    Zeimet, A.
    Fiegl, H.
    Marth, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] PD-1/PD-L1 Pathway in Breast Cancer
    Schuetz, Florian
    Stefanovic, Stefan
    Mayer, Luisa
    von Au, Alexandra
    Domschke, Christoph
    Sohn, Christof
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (05) : 294 - 297
12345